Anti-metabolite Therapy Against Zika virus replication

Alondra D. Torres-Gerena Author

07/28/2021 Added

19 Plays

Description

Anti-metabolite Therapy Against Zika virus replication. Effects that 6-Aminonicotinamide has in infected cells & metabolic pathway(s).

Searchable Transcript

Search:

[00:00:00.660]Hi, my name is Alondra Torres.
[00:00:02.340]My project is "Anti-metabolite Therapy Against ZIKA virus replication."
[00:00:07.890]My mentor and PI is Dr. Rodrigo Franco
[00:00:12.940]Zika virus has had
[00:00:14.122]multiple outbreaks in every part of the world,
[00:00:18.640]particularly in Brazil, United States, Puerto Rico,
[00:00:22.600]and other countries.
[00:00:24.280]So you see microcephaly is one of the
[00:00:28.690]symptoms that could appear in babies. And you see,
[00:00:33.520]in 2014, the cases were lower, and 2015 and 16,
[00:00:38.440]they incremented dramatically.
[00:00:41.920]Also, this illness is associated with Guillain- Barre Syndrome.
[00:00:49.390]These results were the basis of my research.
[00:00:53.570]A grad student was already working with this drug called 6-aminonicotinamide
[00:00:59.387]also known as 6-AN.
[00:01:02.320]So this drug had an interesting effect. You see,
[00:01:06.010]this is non-treated with 6-AN
[00:01:09.160]nd infected with ZIKA virus, and this is infected but treated with 6-AN.
[00:01:12.400]You see the depletion in infection here.
[00:01:17.110]So what, so why does this happen? Well, you see,
[00:01:21.760]there is two enzymes called
[00:01:26.680]G6PD and 6PGD.
[00:01:31.270]These two enzymes. Drug is supposed to act on the pentose phosphate
[00:01:35.770]pathway.
[00:01:37.330]So what this drug was supposed to do,
[00:01:40.870]it was supposed to inhibit this, and this enzyme,
[00:01:45.820]and that's what we thought that
[00:01:50.260]occurred for this depletion.
[00:01:54.250]In this Western blot, you can see, we did a knockdown.
[00:01:58.630]So, in this Western blot, you can see the knockdown,
[00:02:03.100]but you can also see that it has no effect,
[00:02:06.880]cause this is the treated with 6-AN,
[00:02:11.260]and you can see the knockdowns,
[00:02:15.130]but you can also see that even if it's treated with 6-AN, there is
[00:02:20.260]no inhibition of the protein production of ZIKA virus.
[00:02:25.990]The purpose is to understand how 6-AN has an effect on ZIKA
[00:02:30.820]infection. Our hypothesis is that 6-AN
[00:02:34.060]interferes with NAD.
[00:02:36.820]This causes the depletion of multiple pathways since
[00:02:40.987]NAD is needed in most of them.
[00:02:46.060]Since we believe that 6-AN is affecting NAD,
[00:02:51.040]it affects multiple pathways as well.
[00:02:54.460]If it affects multiple pathway,
[00:02:57.610]it will change the metabolical processes.
[00:03:00.430]This is why we're doing the studies and observing which pathways and
[00:03:05.410]what it's doing to each pathway.
[00:03:09.060]The graph that we see here was provided by the 1D
[00:03:13.920]1H NMR machine that you can see here as well.
[00:03:18.374]This data shows that 6-AN
[00:03:23.190]and treated and non-treated cells have a drastic
[00:03:27.930]difference between the NAD production.
[00:03:31.620]As you can see here, there is significant statistical data.
[00:03:36.730]For us to compile the data that we needed for cell metabolism,
[00:03:40.480]we used a machine called Seahorse. This machine,
[00:03:45.160]what it does is it takes protein efflux rates through time.
[00:03:50.140]So it measures the flux. For first of all,
[00:03:53.320]you get the basal glycolysis, and then you treat it with
[00:03:58.090]Rotenone, and it blocks the carbons in going into the mitochondria,
[00:04:03.730]and that is why the lactate glycolysis
[00:04:09.550]is increased dramatically.
[00:04:13.780]If you can see how you can see what I am explaining,
[00:04:18.400]and also after this,
[00:04:20.770]you can have the compensatory glycolysis data.
[00:04:25.570]Then you treated with 2-DG, which what it does,
[00:04:30.520]it just inhibits this completely.
[00:04:34.600]So, it decreases immensely.
[00:04:37.860]So, in this graph,
[00:04:39.660]you can see the difference between treated and non-treated cells.
[00:04:43.980]You can see ZIKA plus 6-AN
[00:04:47.100]has a depletion significant in
[00:04:51.240]glycolosis,
[00:04:53.160]and here, in basal glycolysis,
[00:04:56.430]you can see the treated and non-treated,
[00:05:03.750]and here, in the compensatory glycolysis,
[00:05:06.690]you can see that treated and non-treated have a
[00:05:11.130]significant statistical data:
[00:05:15.420]is proof that 6-AN does have an
[00:05:21.180]effect on glycolysis,
[00:05:25.230]and it's demonstrated by the flux and Seahorse, because you
[00:05:30.150]can see that cells that have been treated have
[00:05:34.980]depleted.
[00:05:36.690]The data so far does demonstrate that 6-AN inhibits NAD,
[00:05:41.910]which is proven that our hypothesis is correct. However,
[00:05:46.740]we do need to keep experimenting and doing some measuring
[00:05:51.630]of any NAD with infected cells and adding precursors as
[00:05:56.220]well. I would like to thank my PI and mentor,
[00:06:00.680]Dr. Rodrigo Franco.
[00:06:02.720]I would also like to thank Dr. Bikash Sahoo,
[00:06:07.910]and I would also like to thank my grad student Alexandra Crook,
[00:06:13.490]and everyone else who had a part of this project and who helped me
[00:06:18.170]during the summer to complete and have the data that I needed for it,
[00:06:23.000]and I also like to thank UNL for the opportunity to work on this project.

The screen size you are trying to search captions on is too small!

You can always jump over to MediaHub and check it out there.

Comments

0 Comments

Anti-metabolite Therapy Against Zika virus replication

Description

Searchable Transcript

Comments icon comment

Related Channels

Comments